Call Us Free: (800) 394-2767

Medtronic will pay $51 million to settle federal complaints over ev3 marketing

Medtronic has agreed to pay $51 million to settle federal complaints over marketing tactics used by Covidien and ev3, two other medical-technology businesses that are now part of Medtronic.

Reuters reports on the settlement by Medtronic (NYSE: MDT), which is based in Ireland but has its operational headquarters in Fridley, Minn. The deal includes a $17.9 payment, and a guilty plea by ev3 Inc. related to marketing a neurovascular medical device for unapproved uses. Prosecutors had claimed ev3’s…

Source link

Leave a Reply